Award-winning biotechnology company enabling manufacturers to more ethically ensure their products are safe from harmful chemicals.
There are over 100,000 commercially available chemicals, but little is known about the effects many of those chemicals have on people. Vitargent is a biotechnology company that is pioneering the field of safety testing technology to make animal testing a thing of the past. By using medaka and zebrafish embryos to perform toxicity tests, Vitargent's solution is more comprehensive than chemical testing and more ethical than animal testing. They test at checkpoints along the supply chain, ensuring quality control at every stage of the production process. Clients include global cosmetics and skincare companies, food and beverage conglomerates, leading testing laboratories, and governments. Vitargent is the only ISO17025 accredited laboratory in Asia that provides fish embryo-based toxicity testing.
Notable Achievements
- Investors include PwC, G.E.M. (China's Taylor Swift)
- Owner of the world's largest biotoxicity & efficacy database on FMCGs
- Company with deep technologies recognized as one of the Technology Pioneers by World Economic Forum
Currently Operating in Seven Regions
Press Mentions
December 10, 2021
Building Global Sustainability with the Power of Partnerships - SPONSOR CONTENT FROM UNREASONABLE IMPACT
Sponsor content from Unreasonable Impact.
Read on Harvard Business Review »June 29, 2018
PwC Hong Kong signs investment agreement with biotech and internet platform company Vitargent
PwC Hong Kong ("PwC") has entered into an investment agreement today with Vitargent International Holdings Limited ("Vitargent"), a pioneer in bio-testing technology for product safety. This is...
Read on Cision »February 2, 2018
Vitargent and PwC to accelerate product safety testing technologies
Vitargent (International) Biotechnology has become a strategic partner with PwC.
Read on foodqualitynews.com »More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on Vitargent and over 402 other ventures working to solve the world's toughest problems.